← Leaderboards
Lubomir Sokol
H. Lee Moffitt Cancer Ctr & Res Inst
$857,042
Attributed
$2,571,126
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $548.5K · FY2019–23$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,571,126 · 1
By mechanism
R01$2,571,126 · 1
Top collaborators
- Jose R Conejo-Garcia5 shared
- Javier Pinilla5 shared
Most similar at H. Lee Moffitt Cancer Ctr & Res Inst
Same institution · by research overlap
- Jose R Conejo-Garcia$21,497,732
- Javier Pinilla$1,917,273
Others in their field
Other Emerging Leaders on “Effective Intervention”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Yunda Huang · Fred Hutchinson Cancer Center$70,809,823
- Susan M Landau · University Of California Berkeley$47,252,026
- Abraham Aizer Brody · New York University School Of Medicine$40,921,532
Research focus
Effective InterventionEffective TherapyAblationDrug CombinationsAmerican Cancer SocietyBinding ProteinsAt Rich SequenceBloodDown-RegulationDiagnosisChemokine ReceptorChromatinClinicClinical InvestigatorBiologicalCollectionCutaneous T-Cell LymphomaCytokineCancer CenterAutomobile DrivingCd4 Positive T LymphocytesDermatologyDesignEpigenetic Drug
Grant awards (5)
Targetable epigenetic mechanism driving Cutaneous T cell Lymphoma$387,981
R01 · FY2023 · CA
Targetable epigenetic mechanism driving Cutaneous T cell Lymphoma$537,558
R01 · FY2022 · CA
Targetable epigenetic mechanism driving Cutaneous T cell Lymphoma$548,529
R01 · FY2021 · CA
Targetable epigenetic mechanism driving Cutaneous T cell Lymphoma$548,529
R01 · FY2020 · CA
Targetable epigenetic mechanism driving Cutaneous T cell Lymphoma$548,529
R01 · FY2019 · CA